We collaborated with Vinmec International Hospital to execute a clinical trial for GXIPC1 for treating diabetes. The stem cells were prepared in Taiwan and shipped to Vietnam under strict temperature monitoring. Each batch 100% passed site-to-site qualification.
This unprecedented trial demonstrates our capability in delivering stem cell products overseas for clinical trials, establishing a landmark in Taiwan’s cell therapy industry.
We continually strive to enhance our delivery processes and partnerships to maintain this level of excellence.
For further inquiries or quotation requests, please feel free to contact us.